to determine the effects of diacerein on Il-1b stimulated chondrocytes under hypoxia conditions. Methods: Articular chondrocytes were obtained from human osteoarthritic knees after enzymatic digestion. Cells were maintained under hypoxia conditions (5% O 2 , 5% CO 2 ) and stimulated with Il-1Beta for 24 h with or without diacerein. NO production was analyzed using the Griess reagent to measure Nitrite in culture medium. iNOS and COX-2 expression was analyzed by confocal microscopy (Leica) after cell immunestaining. Moreover, proliferation and apoptosis of cells in all conditions were also investigated. Human knee cartilage explants were also used in this study. Explants were treated for 24 h with Il-1Beta with or without diacerein to analyze GAG release into the culture medium. Results: Human articular chondrocytes cultured under low oxygen tension respond to Il-1beta by an increase on NO production, reflected by nitrite increase in culture medium. In parallel, an increase on iNOS expression was also observed after stimulation with the cytokine. Moreover, the percentage of apoptotic cells after Il-1Beta treatment was higher than in control where few apoptotic cells were found. When cartilage explants were treated with Il-1Beta, we observed an increase on GAG release in culture medium, reflecting extracellular matrix degradation. When diacerein was added to culture medium containing Il-1Beta, NO production, iNOS expression and apoptosis was markedly inhibited. Moreover, diacerein reduced GAG release from human cartilage explants treated with Il-1b, reflecting an inhibition on matrix degradation. However, no effect of diacerein on COX-2 expression was observed under our experiments conditions. Furthermore, proliferation was no affected in all conditions used. Conclusions: Our results show that diacerein could reduce the procatabolic effects of Il-1Beta on osteoarthritic chondrocytes cultured in conditions mimicking their hypoxic in vivo environment. The results could partly explain the anti-osteoarthritic properties of Diacerein and its disease-modifying effects on OA cartilage. Purpose: The aim of this study was to evaluate the molecular elements involved in the phenotypic changes observed during osteoarthritis (OA) progression in humans and rats. Methods: The experimentally OA-induced model was accomplished by unilateral knee menisectomy and post-surgery training; normal rats were used as a control. Animals were sacrificed by CO2 overdose and right femoral condyle was removed and processed for either electron microscopy (EM) or immunofluorescence (IF). Cartilage samples from rats with 1 to 5 training days (td) were used to evaluate ultrastructural changes by EM. Moreover, cartilage from animals with 3, 6 and 10 td were analyzed by IF for Fas, IFN-g, Il-1b, Il-6, Il-10, MMP3, MMP13, TGF-b1 TLR2, TLR4 and TNF-a. Programmed cell death was detected with TUNEL and IF for caspase 3 and LC3II, in cartilage from rats with 20 and 45 td. At the same time, development of ER and Golgi membranes was monitored with the markers calnexin and 58k-9 respectively. Finally, cryosections from human cartilage were stained with the raft marker cholera toxin B subunit. Fluorescent signals were analyzed by confocal microscopy. Results: Electron microscopy revealed changes in the superficial zone chondrocytes, where the cell phenotype changed from elongated to a rounded shape. During the first 5 td, chondrocytes developed prominent ER with dilated cisterns and enhanced Golgi membranes. Expression of the proinflammatory cytokines IL1-b, TNF-a and Il-6 began at 6 td, in the superficial zone and reached their highest levels at 10 td in all the cartilage zones. TGF-b1 showed a similar profile. In contrast, IFN-g showed high levels at 6 td that decreased at 10 td. Expression of Il-10 remained without changes during the time-course of the experiment. MMP-3, MMP-13, TLR2 and TLR4 raised their levels in a time dependent manner in all cartilage zones. Cell death analysis, revealed expression of molecules involved in both autophagy (LC3II) and apoptosis (TUNEL and caspase 3) at 20 and 45 td. Expression of 58k-9 and calnexin in cartilage from rats with 20 and 45 td were increased. Finally, in situ lipid rafts (LR) were increased in OA cartilage compared with normal donors, in both superficial and medial zone chondrocytes. Conclusions: Our results suggest that during OA progression chondrocytes undergo dramatic phenotypic changes and display signaling transduction machinery capable of inducing its own morpho-functional changes. In early OA, chondrocytes increase ER and Golgi in order to synthesize proteins required for reparation of ECM. However, when the repair capacity is overwhelmed, chondrocytes begin the synthesis of catabolic molecules like Il-1b, Il-6, TNF-a, MMP3 and MMP-13 that stimulate an inflammatory process and degradation of ECM. The expression of catabolic proteins could be regulated via Fas or TLR activation. The signaling activation could take place in LR, since, our results provides evidence that in situ clustered LR are enhanced in OA cartilage. Furthermore, the decrease of anti-inflammatory molecules in OA could be involved in the beginning of the disease. Finally, when chondrocytes lost their reparative capacity, execute its own cell death program that include both autophagy and apoptosis. 
Purpose:
The aim of this study was to evaluate the molecular elements involved in the phenotypic changes observed during osteoarthritis (OA) progression in humans and rats. Methods: The experimentally OA-induced model was accomplished by unilateral knee menisectomy and post-surgery training; normal rats were used as a control. Animals were sacrificed by CO2 overdose and right femoral condyle was removed and processed for either electron microscopy (EM) or immunofluorescence (IF) . Cartilage samples from rats with 1 to 5 training days (td) were used to evaluate ultrastructural changes by EM. Moreover, cartilage from animals with 3, 6 and 10 td were analyzed by IF for Fas, IFN-g, Il-1b, Il-6, Il-10, MMP3, MMP13, TGF-b1 TLR2, TLR4 and TNF-a. Programmed cell death was detected with TUNEL and IF for caspase 3 and LC3II, in cartilage from rats with 20 and 45 td. At the same time, development of ER and Golgi membranes was monitored with the markers calnexin and 58k-9 respectively. Finally, cryosections from human cartilage were stained with the raft marker cholera toxin B subunit. Fluorescent signals were analyzed by confocal microscopy. Results: Electron microscopy revealed changes in the superficial zone chondrocytes, where the cell phenotype changed from elongated to a rounded shape. During the first 5 td, chondrocytes developed prominent ER with dilated cisterns and enhanced Golgi membranes. Expression of the proinflammatory cytokines IL1-b, TNF-a and Il-6 began at 6 td, in the superficial zone and reached their highest levels at 10 td in all the cartilage zones. TGF-b1 showed a similar profile. In contrast, IFN-g showed high levels at 6 td that decreased at 10 td. Expression of Il-10 remained without changes during the time-course of the experiment. MMP-3, MMP-13, TLR2 and TLR4 raised their levels in a time dependent manner in all cartilage zones. Cell death analysis, revealed expression of molecules involved in both autophagy (LC3II) and apoptosis (TUNEL and caspase 3) at 20 and 45 td. Expression of 58k-9 and calnexin in cartilage from rats with 20 and 45 td were increased. Finally, in situ lipid rafts (LR) were increased in OA cartilage compared with normal donors, in both superficial and medial zone chondrocytes. Conclusions: Our results suggest that during OA progression chondrocytes undergo dramatic phenotypic changes and display signaling transduction machinery capable of inducing its own morpho-functional changes. In early OA, chondrocytes increase ER and Golgi in order to synthesize proteins required for reparation of ECM. However, when the repair capacity is overwhelmed, chondrocytes begin the synthesis of catabolic molecules like Il-1b, Il-6, TNF-a, MMP3 and MMP-13 that stimulate an inflammatory process and degradation of ECM. Methods: Thirty male albino rats were divided into six groups: I immobilized; IS7 immobilized and stretched seven days/week; IS3 immobilized and stretched three days/week; S7 stretched seven days/week; S3 stretched three days/week and C control. These groups were used in this experiment. The I, IS3 and IS7 groups were immobilized for 4 weeks. In the muscle stretching protocol, the treated ankle joint (groups IS3, IS7, S3 and S7) was manually full dorsal flexed 10 times for 60 s with a 30 s interval between each 60 s period, 7 or 3 days a week for 3 weeks, to stretch the ankle plantar flexor muscle group. The right hind limb was free to move. At the end of the experiment, the ankles were removed, processed in paraffin and stained with Safranin-O to evaluate the proteoglican response. Two blinded observers evaluated the Safranin-O staining, from treated and non-treated hind limbs using a light microscope. To compare loss of safranin-o staining graduation among groups it was used Kruscal Wallis and post hoc Newman Keuls statiscal analysis. Results: All the groups, except the group stretched for 7 days a week presented proteoglican loss in the non-treated limbs compared to the controls. The higher loss in the non-treated limbs was found in the animals from groups immobilized and stretched for 3 and 7 days a week. Concerning the treated hind limbs, all groups, except the group stretched for 7 days a week presented proteoglican loss compared to the controls. As well as the non treated limbs, the higher proteoglican loss was in the immobilized and stretched for 3 and 7 days a week group. Conclusions: According to the results of the present study, the articular cartilage is susceptible to proteoglican loss having different stimuli. However, immobilization, different frequencies of stretching, overload in the contralateral limb and immobilization followed by muscle stretching caused different degrees of loss. The present muscle stretching protocol applied after immobilization seems to be a trigger of harm to both limbs, treated and contralateral when applied daily or on alternate days. Purpose: Osteoarthritis (OA) is the most common rheumatologic disease involving cartilage alterations in both proteoglycans and the collagen network. One of the proteoglycan families is the small leucine rich proteoglycans (SLRPs). SLRPs are characterized by their association with collagen fibrils. Opticin is a glycoprotein and class III member of the SLRP family, which was initially identified to be associated with the collagen fibrils of the vitreous humor of the eye. Recently, we showed that opticin is present in human articular tissues, and that MMP-13, the key metalloprotease involved in cartilage pathology, cleaves human cartilage opticin. Here, we examined the ability of other human MMPs and ADAMTS involved in OA pathology to cleave opticin and investigated their patterns of degradation.
DEGRADATION OF OPTICIN, A MEMBER OF THE SMALL LEUCINE-RICH REPEAT PROTEOGLYCANS FAMILY, BY METALLOPROTEASES AND ADAMTS INVOLVED IN OSTEOARTHRITIS

Methods:
Opticin was extracted from normal and OA human cartilage using guanidinium chloride (4 M) extraction and examined by Western blotting. Human MMP 1, -2, -3, -7, -8, -9 and ADAMTS-4, -5 proteolytic activities on opticin were analyzed on normal and OA cartilage extracts incubated for 0−24 hours Results: One of the emerging observations was that all MMPs and ADAMTS tested, except MMP-9, cleaved opticin in both normal and OA specimens. Interestingly, MMP-7 and -8 were the most effective, and degradation occurred as early as 15 minutes of incubation. At which time, degradation was almost complete for MMP-7, suggesting that this molecule is a preferential substrate for this enzyme. In contrast, MMP-1 was the least effective and degradation was noted after an incubation of 16 hours. The others enzymes showed degradation starting at about 2 hours. The degradation pattern, except for MMP-7 in which degradation appeared independent of the specimen types, was different between normal and OA. In general, the degradation pattern was slower in normal than in OA specimens, reflecting an increased sensitivity of opticin to degradation when the cartilage was damaged. Fragments were also detected, but the number and size differed depending on the protease. This indicates different digestion sites among the proteases. Surprisingly, MMP-1 and -2 generated different opticin degradation fragments when normal were compared to OA specimens. The different opticin protease cleavage sites are currently under study.
Conclusions:
We showed, for the first time, the ability of different MMP and ADAMTS to degrade opticin. As opticin may contribute to the structural stability of cartilage matrix, its cleavage may predispose cartilage to degradation. In vivo identification of the cleavage products may assist in an early detection of OA cartilage matrix degeneration. 
DYSREGULATION OF GLUCOSE TRANSPORT AND GLUT-1 PROTEIN IN OSTEOARTHRITIC CHONDROCYTES IN RESPONSE TO HIGH EXTRACELLULAR GLUCOSE
Purpose:
Diabetes mellitus is an important risk factor for osteoarthritis (OA), but the mechanisms involved are largely unknown. In chondrocytes, glucose is essential for energy production and the synthesis of matrix components. Diabetic patients can experience extended episodes of hyper-and hypoglycemia that are likely to affect the delivery of glucose to the synovial joint and its availability to chondrocytes. Glucose transport is the limiting step in glucose utilization and the facilitative glucose transporter-1 (GLUT-1) is the major glucose transporter in chondrocytes. This study aimed at comparing the ability of normal and OA chondrocytes to regulate glucose uptake and GLUT-1 levels in response to high and low extracellular glucose concentrations. Methods: Normal human chondrocytes were isolated from the femoral condyles of multi-organ donors. OA chondrocytes were isolated from the cartilage obtained from patients undergoing total knee replacement surgery. Serum-starved subconfluent chondrocyte cultures were incubated in media with 0, 10 or 30 mM glucose. Total GLUT-1 content was evaluated by western blotting. Glucose transport was determined by measuring the uptake of non-metabolizable 2-Deoxy-D-2-[2,6-3 H] glucose into chondrocytes for 30 minutes at 37ºC. GLUT-1 gene expression was measured by Real Time PCR. To determine the role of lysosomes in GLUT-1 regulation, chondrocyte cultures in regular (10 mM glucose) or high glucose (30 mM) medium were treated with 20 mM chloroquine, an inhibitor of lysosome function, for the last 6 hours of an 18 hour incubation period. Results: Treatment of normal chondrocytes with 30 mM glucose for either 18 or 48 hours significantly decreased 2-Deoxy-D-Glucose uptake (75.4±3.6% and 71.5±2.6%, respectively) and GLUT-1 protein levels (68.2±9.1% and 64.6±6.0%, respectively) relative to cells cultured under 10 mM glucose. In contrast, 2-Deoxy-D-Glucose uptake (102.5±3.1%) and GLUT-1 levels (116.51±9.6%) remained unchanged in OA chondrocytes cultured for 48 hours in the high glucose medium. GLUT-1 mRNA levels, either in normal or OA chondrocytes, were not affected by treatment with high glucose for 6, 12 or 24 h. Similarly to normal cells, OA chondrocytes responded to glucose deprivation by increasing 2-Deoxy-D-Glucose uptake (128±2%) and total GLUT-1 levels (137.8±8.6%). Treatment with 20 mM chloroquine significantly increased total GLUT-1 protein in normal chondrocytes, both under regular (10 mM) and high glucose conditions. Conclusions: OA chondrocytes are capable of upregulating the net rate of glucose transport and GLUT-1 protein when deprived of glucose, suggesting that they are capable of sensing and adjusting to low extracellular glucose concentrations. However, unlike normal chondrocytes, OA chondrocytes fail to downregulate glucose transport and GLUT-1 protein under high glucose concentrations. This may lead to an abnormally high intracellular glucose concentration, which in turn may lead to altered cell function and the formation of glycation end products during extended periods of hyperglycemia in vivo. The lack of significant differences in GLUT-1 mRNA, together with GLUT-1 accumulation in normal chondrocytes exposed to chloroquine, indicate that GLUT-1 downregulation depends on lysosomal degradation. The role of lysosomal function in the inability of OA chondrocytes to adequately respond to high glucose remains to be elucidated. Purpose: Previously we have shown that cartilage chondrocyte alkaline phosphatase (ALP) is up regulated in active osteoarthritis (OA) and down regulated in calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. Furthermore, CPPD crystals can be dissolved by the action of ALP provided that the enzyme is bound to the crystals. Modulating the action of ALP would then suggest a possible route to affect these conditions. To obtain a better understanding of the action of ALP on CPPD crystal dissolution, we investigated inhibition by endogenous amino acids on ALP substrates; organic phosphate, inorganic pyrophosphate, and CPPD crystals. Methods: CPPD crystals were made using established methods developed in our laboratory. The phosphatase (Piase), pyrophosphate hydrolase (PPiase), and CPPD crystal dissolution activities of tissue nonspecific alkaline phosphatase (TNAP) were investigated in vitro using cysteine and mercaptopyruvate (MPA) as inhibitors of Bovine kidney ALP. Enzyme activity was determined by measuring liberated inorganic phosphate (Pi) from p-Nitrophenyl phosphate (pNPP), or Sodium pyrophosphate, at specific times and conditions. CPPD crystal dissolution was assessed by measuring [Pi] liberated into solution in the presence of TNAP. To assess enzyme inhibition, kinetics parameters such as Vmax and Km, were determined and specific activities were calculated from Initial Velocity, Eadie-Hofstee, Simple, Dixon, and Secondary plots. Assays were run under physiologic conditions with Tris-HCl buffer, pH = 7.4 and at 37ºC. TNAP was at 200U/L and the buffer was supplemented with 1 mM Ca ++ and 1 mM Mg ++ . Enzyme activity was expressed as nmoles Pi/unit TNAP/minute. Results: At physiologic concentration, cysteine had no inhibitory effect on any activity of TNAP. At 10× physiologic concentration, cysteine significantly inhibited phosphatase and pyrophosphate hydrolase activity but did not inhibit CPPD crystal dissolution. MPA and cysteine together inhibited TNAP's phosphatase and pyrophosphate hydrolase activity at physiologic concentration while CPPD crystal dissolution was only slightly inhibited. When the two inhibitors were increased to 10x physiologic concentration, all enzyme activity decreased significantly as is shown in the summary 
Conclusions:
The amino acids cysteine and MPA together are capable of inhibiting phosphatase and pyrophosphate hydrolase activity of TNAP at
